Introduction: Pathological calcium-containing crystals accumulating in the joints, synovial fluid, and soft tissues are noted in most elderly patients, yet arthritic crystal formation remains idiopathic. Interestingly, elevated lactic acid and bone erosion are frequently among the comorbidities and clinical features of patients with highest incidence of crystal arthropathies. This work shows that bone particulates (modeling bone erosion) dissolve in lactic acid and directly generate crystals, possibly presenting a mechanism for crystal accumulation in osteoarthritis.
Introduction
Osteoarthritis (OA) is the most prevalent human joint disorder and a leading cause of disability 1 . However, with its complex and likely multifactorial pathogenesis, OA remains idiopathic. Poor understanding of OA etiology has meant poor therapeutic options 2 , with progressive destruction leading to total joint replacement. At least 70% of OA synovial fluid samples have calcium-containing crystals 3 , yet whether crystals are at the root of OA or are downstream in relation to joint damage is under debate 4 . Pathological calcium and phosphate containing crystals in osteochondral regions of joints, in the surround joint soft tissue and in synovial fluid are commonly noted in most forms of osteoarthritis 5, 6 . Basic calcium phosphate (BCP) and calcium pyrophosphate dehydrate (CPP) are the most commonly found crystals in articular cartilage and synovial fluid 7 , along with, very rarely, calcium oxalate monohydrate (COM) 8 . However, multiple species of crystals are often found together in the same patient sample 8 .
Besides gout, calcium pyrophosphate deposition disease (CPPD) (or pseudogout)
is the most common idiopathic crystal arthropathy 5, 6 , with knee as the most commonly involved joint, yet with polyarticular crystal deposition seen in two-thirds of patients.
CPPD is estimated to affect 15% of people aged 65-74, and 50% of people age 84 or older 5, 9 . CPP crystals present as rhomboid or rod-shaped structures and are weakly positive in birefringence under compensated polarized light microscopy, while the crystals are nonbirefringnent for BCP deposition diseases 10 . There is no known effective method of removing calcium-containing crystals deposited in the synovium, bound to cartilage (common in CPP) or soft tissues.
The non-apatitic carbonate and phosphate groups on bone minerals (calcium phosphate [Ca 3 (PO 4 ) 2 ] or hydroxyapatite [Ca 10 (PO 4 ) 6 (OH) 2 ]) are reported to be very biologically active, which may lead to dissolution of the hard tissue such as in normal remodelling 11 . CPP (Ca 2 PO 7 ) or BCP may thus be generated as crystals from the breakdown of bone in the presence of reactive lactic acid (C 3 O 6 H 3 ) or lactate (CH 3 CH(OH)COO -). Further, CPPD is reportedly somewhat difficult to distinguish from erosive OA clinically 12 , linking bone particulate to arthritic crystals.
In humans, normal resting lactic acid levels range from 0.5-1.8 mmol/L. However, when CPP crystals are detected, 4.2-11.2mmol/L of lactic acid has been reported, with elevated pH 13 , and up to 10-24 times normal levels in the synovial fluid for rheumatoid arthritis and OA 13 . Lactic acid elevation is further a recurring clinical feature in crystal arthropathy comorbidities (Table 1) , along with bone erosion. It is thus hypothesized that lactic acid, or lactate, and eroded bone (modeled here with human micronized bone particulate) directly generate calcium and phosphate-containing crystals, suggesting joint lactic acidosis is directly mechanistically linked to crystal arthropathies. Supporting this hypothesis, this work reports an original model system of micronized mineralized bone suspended in synovial fluid in the presence of acids to study bone-derived crystal formation. Germany) then observed microscopically with normal and polarizing light daily for two weeks. were used dry and at 100mg/ml in lactic acid to generate a Raman reference library to compare the crystals generated from bone in lactic acid sample. Lactic acid alone was analyzed to assess background interference. Micro-Raman at 633nm was performed at ChemXLerate (Ann Arbor, MI) for bone in lactic acid samples.
Synovial Fluid Collection and Crystal Formation

Acid Treatments of Bone and Minerals
Results
Crystal generation from bone in lactic acid
Of the nine acids tested, only lactic acid was found to dissolve and liquefy mineralized (but not demineralized) bone particulate in the sub 125-micron diameter particle size range (henceforth referred to as "bone" per this Phosphoric and trifluoroacetic acids dissolved mineralized and demineralized bone but did not form crystals.
Under normal and polarized light microscopy, a donor knee synovial fluid sample with pathologic crystals was found containing positively birefringent rod-shaped crystals ( Figure 1A,B) as a reference control. Adding 500mMol of lactic acid with 100mg/mL of bone to the healthy synovial fluid (negative control, no crystals present initially) generated birefringent rod-shaped crystals in the synovial fluid by 5 days of 37°C incubation ( Figure   1C ,D), with groups exposed to a lower concentration of lactic acid (100mM) and mineralized bone in normal synovial fluid formed rod-shaped crystals at 2 weeks (not shown). The dissolved rhomboid and rod-shaped crystals from bone exhibited positive birefringence in both 500mMol lactic acid in human synovial fluid (Figure 1D) , and also formed crystals with micronized bone directly dissolved into 85% lactic acid ( Figure   1E,F) , comparable to control diseased synovial fluid with crystals ( Figure 1B) .
Birefringence was observed for most, but not all, crystals present. Titration of deionized water to the crystal samples progressively resulted in shrinkage and dissolution of the crystals. 
Crystal Elemental Analysis
SEM analysis with EDS of micronized mineralized bone alone (Figure 3A) is compared to crystals generated from bone in synovial fluid with 500mMol lactic acid ( Figure 3B) , the latter of which showed atomic percentages of calcium and phosphate in the crystals at ratio of O:Ca:P at 8.64:1.85:1 (n=5). Micro-Raman spectroscopy (633nm) of crystals from bone in lactic acid did not detect the peak for hydroxyapatite at 960/cm yet the spectrum does contain the dominant 1049/cm band used to diagnose CPPD clinically ( Figure 3C ), suggesting the presence of Ca-O and P-Ca bonds. This 1049/cm peak was also seen in CPP crystals controls, but not BCP in lactic acid, as tested by Raman spectroscopy at 532nm (not shown). EDS was performed on two individually processed donors for each condition (n=2), yielding elemental composition results that were not significantly different. Micro-Raman spectroscopy analysis was performed on lactic acid (LA) with micronized mineralized bone-generated crystals (labeled as "LA + mBone Crystals 1 & 2") and compared to lactic acid alone, with imaging targeted at a single crystal for analysis. A dominant peak seen at 1049/cm (using 633nm spectroscopy) is shown in the experimental traces (C),
which is a peak commonly reported for calcium pyrophosphate crystals clinically.
Further, the hydroxyapatite peak (commonly reported at 960/cm) is absent, yet a slight peak is noted around 900/cm, indicative of calcium oxalate monohydrate.
Discussion
Better understanding of the causes of crystal formations are still needed to reduce, treat, or prevent the formation and deposition of arthritic crystals. Lactic acid has been considered a byproduct or correlated feature of arthritis involving crystals for decades 13 .
This work presents a hypothetical pathogenesis for calcium-containing crystal, where micronized bone (modeling eroded bone) and lactic acid are directly shown to generate crystals analogous to those common in various forms of OA (Figure 4) , being the first time this has been experimentally reported. Bone is solubilized in lactic acid to form crystals, as may be occurring in arthritic bone and cartilage from erosions. For synovial fluid, 500mMol of lactic acid was required in around 5 days of exposure to generate rhomboid and rod-like crystals (Figure 1) . Below, we propose a possible mechanism for the reaction of lactic acid and hydroxyapatite (Scheme 1) to form crystals. In the first step, lactic acid reacts with hydroxyapatite at the site of calcium forming intermediate 1. In this study, while the lactic acid concentrations used are higher than physiologic, the reaction kinetics of the acid with bone would occur at lower concentrations as well, albeit with requisite additional reaction time. The higher concentrations of lactic acid tested where thusly chosen to speed the chemical reaction to facilitate analyses. Lactic acid dissolved bone crystals dissolved under increased hydration, similar to clinical reports 13 suggesting hydration as a possible therapeutic consideration and perhaps related to the 33% decrease in body water content in the elderly compared to the young 14 . While the size of the crystals generated in this study are larger than those seen clinically for CPP or BCP, the high saturation of bone and higher acid concentration tested may allow for crystallization to occur beyond what is common clinically.
SEM-EDS results of micronized bone in 85% lactic acid and of micronized bone in 500mMol of lactic acid in synovial fluid show the presence of oxygen:calcium;phosphate in the crystals at a ratio of 8.64:1.85:1 (Figure 3) . This ratio is not perfectly fitting with CPP (Ca:P at 1:1) or BCP (Ca:P at 2:1), yet as the samples are of dissolved bone crystals in wet solution, free bone salts in the solution may be interfering with the measurements.
Raman spectroscopy was thus used to further identify the crystals, where the spectra indicated a dominant peak at 1049/cm, positively identifying CPP, whereas the hydroxyapatite peak at 960/cm is absent, with a slight peak at around 910/cm suggesting calcium oxalate crystals (Figure 3) . The reference library generated from all Raman samples at 532nm suggested that lactic acid dissolved bone samples were most similar to CPP controls.
Review of the literature ( Table 1) For additional future directions, it may prove informative to test synovial membrane cells from normal and OA individuals to assess if either tends to produce more lactic acid. Interestingly, synovial fluid further contains the lactic acid dehydrogenase (LDH) enzyme, suggesting importance of joint-lactic acid balance 15 . LDH therapy (e.g.
gene therapy) may further be tested in animal models for controlling crystal-containing OA. Further, lactic acid may be administered to animals to potentially induce bone erosion, OA and crystal formation, possibly even spurring rheumatoid arthritis symptoms.
Conclusion
We report on a proposed model for the etiology of osteoarthritis with crystal involvement, where eroded bone particulate in the presence of lactic acid are shown to directly generate calcium-containing crystals. These observations are significant because of the current idiopathic nature of calcium-containing crystal arthropathies. This work shows that lactic acid, a common acid in the body that accumulates with age and with disease, is remarkably found to experimentally dissolve bone particulate and he dissolved bone salts form stable crystals that resemble those found in some forms of osteoarthritis.
These results and the hypothesis herein present a plausible direct cause of osteoarthritis with crystal involvement from local eroded bone and the elevated lactic acid in the synovial fluid and systemically, as is commonly reported with osteoarthritis.
